Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Body composition and its role in development of metabolic disorders and cardiovascular diseases

Драпкина О. М., Купрейшвили Л. В., Фомин В. В.
Кардиоваскулярная терапия и профилактика
Т. 16, Вып. 5, С. 81-85
Опубликовано: 2017
Тип ресурса: Статья

DOI:10.15829/1728-8800-2017-5-81-85

Аннотация:
There are many methods of the body composition assessment, but the most relevant are computed tomography and magnete-resonance tomography. Composition of the body shows the rate of fat amount and distribution in metabolic syndrome (MS) patients. It is known that MS increases the risk of atherosclerosis, arterial hypertension, type 2 diabetes, with further significant increase of cardiovascular morbidity and mortality. MS is associated with subclinical damage of internal organs; and the role of abdominal obesity is high. However, till recently there is no unified understanding of the role of visceral and subcutaneous fat.
Ключевые слова:
Body composition; Metabolic syndrome; Subcutaneous fat; Visceral fat
Язык текста: Русский
ISSN: 2619-0125
Драпкина О. М. Оксана Михайловна 1969-
Купрейшвили Л. В. Лали Велодиевна 1984-
Фомин В. В. Виктор Викторович 1978-
Drapkina O. M. Oksana Mikhaylovna 1969-
Kuprejshvili L. V. Lali Velodievna 1984-
Fomin V. V. Viktor Viktorovich 1978-
Body composition and its role in development of metabolic disorders and cardiovascular diseases
Текст визуальный непосредственный
Кардиоваскулярная терапия и профилактика
ООО "Силицея-Полиграф"
Т. 16, Вып. 5 С. 81-85
2017
Статья
Body composition Metabolic syndrome Subcutaneous fat Visceral fat
There are many methods of the body composition assessment, but the most relevant are computed tomography and magnete-resonance tomography. Composition of the body shows the rate of fat amount and distribution in metabolic syndrome (MS) patients. It is known that MS increases the risk of atherosclerosis, arterial hypertension, type 2 diabetes, with further significant increase of cardiovascular morbidity and mortality. MS is associated with subclinical damage of internal organs; and the role of abdominal obesity is high. However, till recently there is no unified understanding of the role of visceral and subcutaneous fat.